This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, E L
Right arrow Articles by Ellis, M N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, E L
Right arrow Articles by Ellis, M N

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1991 November; 35(11): 2322-2328

In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.

E L Hill, G A Hunter and M N Ellis

Division of Virology, Burroughs Wellcome Co., Research Triangle Park, North Carolina 27707.

ABSTRACT

A total of 100 herpes simplex viruses isolated from lesions not responding to acyclovir (ACV) therapy were recovered from 51 patients infected with human immunodeficiency virus. In vitro analysis of these isolates included testing their susceptibility to ACV and determining their thymidine kinase (TK) phenotypes. Of the 100 isolates evaluated, 23 were ACV sensitive and 77 were ACV resistant. Seventy-four of these ACV-resistant isolates were of the TK-deficient or low-TK-producer phenotype and three were of the TK-altered phenotype. The TKs isolates that represented each of the different autoradiographic phenotypes were further characterized by enzyme kinetics. The ability of selected isolates to cause disease in vivo was evaluated by using several mouse virulence models. Cutaneous virulence in normal and immunocompromised mice was evaluated, and neurovirulence in normal mice was determined. Latent infections were assayed by the cocultivation of trigeminal ganglia recovered from mice that had survived acute infection. These reactivated viruses were evaluated in vitro and compared with the original infecting isolate. The mechanisms of resistance and pathogenicity of these herpes simplex virus isolates recovered from patients positive for human immunodeficiency virus are similar to those reported for isolates recovered from normal and immunocompromised patients without AIDS.


Antimicrob Agents Chemother. 1991 November; 35(11): 2322-2328




This article has been cited by other articles:

  • Wang, K., Mahalingam, G., Hoover, S. E., Mont, E. K., Holland, S. M., Cohen, J. I., Straus, S. E. (2007). Diverse Herpes Simplex Virus Type 1 Thymidine Kinase Mutants in Individual Human Neurons and Ganglia. J. Virol. 81: 6817-6826 [Abstract] [Full Text]  
  • Schnitzler, P., Koch, C., Reichling, J. (2007). Susceptibility of Drug-Resistant Clinical Herpes Simplex Virus Type 1 Strains to Essential Oils of Ginger, Thyme, Hyssop, and Sandalwood. Antimicrob. Agents Chemother. 51: 1859-1862 [Abstract] [Full Text]  
  • Andrei, G., Balzarini, J., Fiten, P., De Clercq, E., Opdenakker, G., Snoeck, R. (2005). Characterization of Herpes Simplex Virus Type 1 Thymidine Kinase Mutants Selected under a Single Round of High-Dose Brivudin. J. Virol. 79: 5863-5869 [Abstract] [Full Text]  
  • Harris, W., Collins, P., Fenton, R. J., Snowden, W., Sowa, M., Darby, G. (2003). Phenotypic and genotypic characterization of clinical isolates of herpes simplex virus resistant to aciclovir. J. Gen. Virol. 84: 1393-1401 [Abstract] [Full Text]  
  • Grey, F., Sowa, M., Collins, P., Fenton, R. J., Harris, W., Snowden, W., Efstathiou, S., Darby, G. (2003). Characterization of a neurovirulent aciclovir-resistant variant of herpes simplex virus. J. Gen. Virol. 84: 1403-1410 [Abstract] [Full Text]  
  • Suzutani, T., Ishioka, K., De Clercq, E., Ishibashi, K., Kaneko, H., Kira, T., Hashimoto, K.-i., Ogasawara, M., Ohtani, K., Wakamiya, N., Saijo, M. (2003). Differential Mutation Patterns in Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus Type 1 Clones Passaged in the Presence of Acyclovir or Penciclovir. Antimicrob. Agents Chemother. 47: 1707-1713 [Abstract] [Full Text]  
  • Bestman-Smith, J., Schmit, I., Papadopoulou, B., Boivin, G. (2001). Highly Reliable Heterologous System for Evaluating Resistance of Clinical Herpes Simplex Virus Isolates to Nucleoside Analogues. J. Virol. 75: 3105-3110 [Abstract] [Full Text]  
  • Suzutani, T., Saijo, M., Nagamine, M., Ogasawara, M., Azuma, M. (2000). Rapid Phenotypic Characterization Method for Herpes Simplex Virus and Varicella-Zoster Virus Thymidine Kinases To Screen for Acyclovir-Resistant Viral Infection. J. Clin. Microbiol. 38: 1839-1844 [Abstract] [Full Text]  
  • Sahli, R., Andrei, G., Estrade, C., Snoeck, R., Meylan, P. R. A. (2000). A Rapid Phenotypic Assay for Detection of Acyclovir-Resistant Varicella-Zoster Virus with Mutations in the Thymidine Kinase Open Reading Frame. Antimicrob. Agents Chemother. 44: 873-878 [Abstract] [Full Text]  
  • Andrei, G., Snoeck, R., De Clercq, E., Esnouf, R., Fiten, P., Opdenakker, G. (2000). Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene. J. Gen. Virol. 81: 639-648 [Abstract] [Full Text]  
  • Ghannoum, M. A., Rice, L. B. (1999). Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance. Clin. Microbiol. Rev. 12: 501-517 [Abstract] [Full Text]  
  • Kost, R. G., Hill, E. L., Tigges, M., Straus, S. E. (1993). Recurrent Acyclovir-Resistant Genital Herpes in an Immunocompetent Patient. NEJM 329: 1777-1782 [Full Text]